Hayfin completes second CLO reset via €398m Emerald II

April 19th 2021

Hayfin today announces the reset of Hayfin Emerald II CLO (“Emerald II”) in a €398.5m transaction, bringing the firm’s recent issuance of European Collateralised Loan…

Read more

Hayfin sees record deployment via Direct Lending strategy

March 31st 2021

Hayfin today announces a record period of deployment through its Direct Lending strategy, having invested €3.7bn in 2020. Hayfin reached a final close on the…

Read more

Hayfin issues €403.8m Hayfin Emerald CLO VI

March 12th 2021

Hayfin today announces the pricing of Hayfin Emerald CLO VI (“Emerald VI”), a €403.8 million Collateralised Loan Obligation (“CLO”). The transaction extends Hayfin’s recent track…

Read more

Hayfin resets €422m Hayfin Emerald I CLO

February 25th 2021

Hayfin today announces the reset of Hayfin Emerald I CLO (“Emerald I”), a Collateralised Loan Obligation (“CLO”) which was first issued in a €412.8m deal…

Read more


Ever Given a Thought to the Suez Canal?

March 28th 2021

Hayfin’s Maritime team discusses how the blockage of the Suez Canal has impacted global shipping markets and may affect future fleet capacity, freight rates and asset pricing


Truffle hunting: looking for value in GP-led private equity secondaries

March 16th 2021

Hayfin’s Private Equity Solutions Team discusses why finding high-quality secondary investment opportunities in the middle market requires a specialist approach and lots of “digging” – much like hunting for truffles.


Healthcare Vital Signs

March 2nd 2021

Hayfin’s Head of Healthcare discusses the divergent impacts of COVID on the diverse sub-sectors of healthcare and the ongoing investment opportunity for specialist lenders.


Relative value beyond the “reflation trade” and through an eventual tightening policy environment

February 16th 2021

Jordan Milman, Hayfin’s Global Head of Structured Products explores the resilience of the asset class within US capital markets through the economic recovery cycle